Dr Gary Weinstein, MD | |
8220 Walnut Hill Ln, Suite 408, Dallas, TX 75231-4427 | |
(214) 361-9777 | |
(214) 891-0084 |
Full Name | Dr Gary Weinstein |
---|---|
Gender | Male |
Speciality | Pulmonary Disease |
Experience | 38 Years |
Location | 8220 Walnut Hill Ln, Dallas, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1275617920 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RP1001X | Internal Medicine - Pulmonary Disease | H6978 (Texas) | Secondary |
207RC0200X | Internal Medicine - Critical Care Medicine | H6979 (Texas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Texas Health Presbyterian Hospital Dallas | Dallas, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Cogent Healthcare Of Texas Pa | 8628076924 | 92 |
News Archive
Children with an autism spectrum disorder may be at greater risk for contemplating suicide or attempting suicide than children without autism, according to Penn State College of Medicine researchers.
BioMarin Pharmaceutical Inc. announced today that the European Commission has granted marketing approval for 3,4-diaminopyridine (amifampridine phosphate), for the rare autoimmune disease Lambert Eaton Myasthenic Syndrome (LEMS).
For people who initially survive a heart attack, a significant cause of death in the next few days is cardiac rupture - literally, bursting of the heart wall. A new study by University of Iowa researchers pinpoints a single protein as the key player in the biochemical cascade that leads to cardiac rupture.
Amgen today announced that the Phase 3 PRIME "203" trial evaluating Vectibix® (panitumumab) administered in combination with FOLFOX (an oxaliplatin-based chemotherapy) as a first-line treatment of metastatic colorectal cancer (mCRC) failed to meet a secondary endpoint of overall survival.
› Verified 4 days ago
Entity Name | Southwest Pulmonary Associates |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1174658454 PECOS PAC ID: 6204733165 Enrollment ID: O20040112000154 |
News Archive
Children with an autism spectrum disorder may be at greater risk for contemplating suicide or attempting suicide than children without autism, according to Penn State College of Medicine researchers.
BioMarin Pharmaceutical Inc. announced today that the European Commission has granted marketing approval for 3,4-diaminopyridine (amifampridine phosphate), for the rare autoimmune disease Lambert Eaton Myasthenic Syndrome (LEMS).
For people who initially survive a heart attack, a significant cause of death in the next few days is cardiac rupture - literally, bursting of the heart wall. A new study by University of Iowa researchers pinpoints a single protein as the key player in the biochemical cascade that leads to cardiac rupture.
Amgen today announced that the Phase 3 PRIME "203" trial evaluating Vectibix® (panitumumab) administered in combination with FOLFOX (an oxaliplatin-based chemotherapy) as a first-line treatment of metastatic colorectal cancer (mCRC) failed to meet a secondary endpoint of overall survival.
› Verified 4 days ago
Entity Name | Cogent Healthcare Of Texas Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1992722953 PECOS PAC ID: 8628076924 Enrollment ID: O20061121000364 |
News Archive
Children with an autism spectrum disorder may be at greater risk for contemplating suicide or attempting suicide than children without autism, according to Penn State College of Medicine researchers.
BioMarin Pharmaceutical Inc. announced today that the European Commission has granted marketing approval for 3,4-diaminopyridine (amifampridine phosphate), for the rare autoimmune disease Lambert Eaton Myasthenic Syndrome (LEMS).
For people who initially survive a heart attack, a significant cause of death in the next few days is cardiac rupture - literally, bursting of the heart wall. A new study by University of Iowa researchers pinpoints a single protein as the key player in the biochemical cascade that leads to cardiac rupture.
Amgen today announced that the Phase 3 PRIME "203" trial evaluating Vectibix® (panitumumab) administered in combination with FOLFOX (an oxaliplatin-based chemotherapy) as a first-line treatment of metastatic colorectal cancer (mCRC) failed to meet a secondary endpoint of overall survival.
› Verified 4 days ago
Entity Name | Hospitalist Medicine Physicians Of Texas - Dallas Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1164174124 PECOS PAC ID: 3678966819 Enrollment ID: O20220210000709 |
News Archive
Children with an autism spectrum disorder may be at greater risk for contemplating suicide or attempting suicide than children without autism, according to Penn State College of Medicine researchers.
BioMarin Pharmaceutical Inc. announced today that the European Commission has granted marketing approval for 3,4-diaminopyridine (amifampridine phosphate), for the rare autoimmune disease Lambert Eaton Myasthenic Syndrome (LEMS).
For people who initially survive a heart attack, a significant cause of death in the next few days is cardiac rupture - literally, bursting of the heart wall. A new study by University of Iowa researchers pinpoints a single protein as the key player in the biochemical cascade that leads to cardiac rupture.
Amgen today announced that the Phase 3 PRIME "203" trial evaluating Vectibix® (panitumumab) administered in combination with FOLFOX (an oxaliplatin-based chemotherapy) as a first-line treatment of metastatic colorectal cancer (mCRC) failed to meet a secondary endpoint of overall survival.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Gary Weinstein, MD 8220 Walnut Hill Ln, Suite 408, Dallas, TX 75231-4427 Ph: (214) 361-9777 | Dr Gary Weinstein, MD 8220 Walnut Hill Ln, Suite 408, Dallas, TX 75231-4427 Ph: (214) 361-9777 |
News Archive
Children with an autism spectrum disorder may be at greater risk for contemplating suicide or attempting suicide than children without autism, according to Penn State College of Medicine researchers.
BioMarin Pharmaceutical Inc. announced today that the European Commission has granted marketing approval for 3,4-diaminopyridine (amifampridine phosphate), for the rare autoimmune disease Lambert Eaton Myasthenic Syndrome (LEMS).
For people who initially survive a heart attack, a significant cause of death in the next few days is cardiac rupture - literally, bursting of the heart wall. A new study by University of Iowa researchers pinpoints a single protein as the key player in the biochemical cascade that leads to cardiac rupture.
Amgen today announced that the Phase 3 PRIME "203" trial evaluating Vectibix® (panitumumab) administered in combination with FOLFOX (an oxaliplatin-based chemotherapy) as a first-line treatment of metastatic colorectal cancer (mCRC) failed to meet a secondary endpoint of overall survival.
› Verified 4 days ago
Uma B.r.k Pakkivenkata, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 9900 N Central Expy Ste 215, Dallas, TX 75231 Phone: 214-396-4950 Fax: 877-423-5360 | |
Dr. Ariel Marcelo Modrykamien, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 3600 Gaston Ave, Wadley Tower, Suite 960, Dallas, TX 75246 Phone: 402-972-6078 | |
Benjamin Seth Martinez, MD Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-648-3111 Fax: 214-648-5461 | |
Vijaya Mummadi, M.D. Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 9900 N Central Expy Ste 225, Dallas, TX 75231 Phone: 469-646-8880 Fax: 469-646-8884 | |
Dr. Ting-yi Chen, M.D. Critical Care Medicine Medicare: Not Enrolled in Medicare Practice Location: 5323 Harry Hines Blvd, Dallas, TX 75390 Phone: 214-645-2800 Fax: 214-645-2808 | |
William Cook Langmade, MD Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 1441 N Beckley Ave, Dallas, TX 75203 Phone: 214-947-2306 | |
Dr. Janame J Kottey, MBBS Critical Care Medicine Medicare: Accepting Medicare Assignments Practice Location: 13154 Coit Rd Ste 100, Dallas, TX 75240 Phone: 214-358-2300 Fax: 214-579-6989 |